These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23388458)

  • 1. Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system.
    Ma Y; Yu WD; Hidalgo AA; Luo W; Delansorne R; Johnson CS; Trump DL
    Cell Cycle; 2013 Mar; 12(5):743-52. PubMed ID: 23388458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
    Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inecalcitol, an analog of 1α,25(OH)(2) D(3) , induces growth arrest of androgen-dependent prostate cancer cells.
    Okamoto R; Delansorne R; Wakimoto N; Doan NB; Akagi T; Shen M; Ho QH; Said JW; Koeffler HP
    Int J Cancer; 2012 May; 130(10):2464-73. PubMed ID: 21732345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model.
    Ma Y; Yu WD; Hershberger PA; Flynn G; Kong RX; Trump DL; Johnson CS
    Mol Cancer Ther; 2008 Sep; 7(9):3047-55. PubMed ID: 18790784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
    Ma Y; Yu WD; Kong RX; Trump DL; Johnson CS
    Cancer Res; 2006 Aug; 66(16):8131-8. PubMed ID: 16912191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor as a target for breast cancer therapy.
    Murray A; Madden SF; Synnott NC; Klinger R; O'Connor D; O'Donovan N; Gallagher W; Crown J; Duffy MJ
    Endocr Relat Cancer; 2017 Apr; 24(4):181-195. PubMed ID: 28213567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eldecalcitol (ED-71), an analog of 1α,25(OH)
    Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
    In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol.
    Ma Y; Yu WD; Su B; Seshadri M; Luo W; Trump DL; Johnson CS
    Cancer; 2013 Feb; 119(3):563-74. PubMed ID: 22833444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D
    Vanhevel J; Verlinden L; Loopmans S; Doms S; Janssens I; Bevers S; Stegen S; Wildiers H; Verstuyf A
    Front Endocrinol (Lausanne); 2022; 13():886238. PubMed ID: 35784555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle arrest and apoptosis induced by 1α,25(OH)2D3 and TX 527 in Kaposi sarcoma is VDR dependent.
    González-Pardo V; Suares A; Verstuyf A; De Clercq P; Boland R; de Boland AR
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():197-200. PubMed ID: 24316429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
    Zinser GM; McEleney K; Welsh J
    Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.
    Luo W; Yu WD; Ma Y; Chernov M; Trump DL; Johnson CS
    Cancer Res; 2013 Apr; 73(7):2289-97. PubMed ID: 23358686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
    Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
    Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
    Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
    Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of hybrid vitamin D receptor agonist/histone deacetylase inhibitors in vitamin D-resistant triple-negative 4T1 breast cancer.
    Bijian K; Kaldre D; Wang TT; Su J; Bouttier M; Boucher A; Alaoui-Jamali M; White JH; Gleason JL
    J Steroid Biochem Mol Biol; 2018 Mar; 177():135-139. PubMed ID: 28847749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia.
    Sharabani H; Izumchenko E; Wang Q; Kreinin R; Steiner M; Barvish Z; Kafka M; Sharoni Y; Levy J; Uskokovic M; Studzinski GP; Danilenko M
    Int J Cancer; 2006 Jun; 118(12):3012-21. PubMed ID: 16395705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth.
    Lambert JR; Eddy VJ; Young CD; Persons KS; Sarkar S; Kelly JA; Genova E; Lucia MS; Faller DV; Ray R
    Cancer Prev Res (Phila); 2010 Dec; 3(12):1596-607. PubMed ID: 21149334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1 Alpha,25-dihydroxyvitamin D3 and its TX527 analog inhibit the growth of endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein-coupled receptor in vitro and in vivo.
    Gonzalez-Pardo V; Martin D; Gutkind JS; Verstuyf A; Bouillon R; de Boland AR; Boland RL
    Endocrinology; 2010 Jan; 151(1):23-31. PubMed ID: 19915163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D Signaling Modulators in Cancer Therapy.
    Luo W; Johnson CS; Trump DL
    Vitam Horm; 2016; 100():433-72. PubMed ID: 26827962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.